About FDA
Minority Health and Health Disparities Research and Collaboration Program
Description: Improve and strengthen regulatory science informing the research and evaluation of sub-population data associations with race and ethnicity through an intramural research program. OMH solicits and selects FDA researchers with projects that address gaps in regulatory science in areas of health dispartities (e.g., markers in Triple-Negative Breast Cancer).
Accomplishment: Funded FY14 projects with the National Center for Toxicological Research (NCTR) and the Center for Biologics Evaluation and Research (CBER); funded FY15 projects with the Center for Drugs Evaluation and Research (CDER), CBER, and NCTR
1. FY14 Projects
Briefing Status: COMPLETED
Prior Briefing Status: COMPLETED
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. Issue funding announcement for intramural studies addressing health disparities and understanding of subpopulations by FDA researchers |
FY13 Q4 |
Completed | FY13 Q4 |
B. Review intramural concept papers and select projects for full proposal development |
FY13 Q4 |
Completed | FY13 Q4 |
C. Complete review and scoring of full proposals, including funding recommendations, by OMH intramural reviewers |
FY14 Q1 |
Completed | FY14 Q1 |
D. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY14 Q2 |
Completed | FY14 Q2 |
E. FDA researchers to submit mid-year progress reports for intramural studies |
FY15 Q2 |
Completed | FY15 Q1 |
F. FDA researchers to submit final reports and complete poster/oral presentations |
FY16 Q2 |
Completed | TBD |
2. FY15 Projects
Briefing Status: COMPLETED
Prior Briefing Status: ON TRACK
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. Issue funding announcement for intramural studies addressing health disparities and understanding of subpopulations by FDA researchers |
FY14 Q3 |
Completed | FY14 Q3 |
B. Complete review and scoring of full proposals, including funding recommendations, by OMH intramural reviewers |
FY15 Q1 |
Completed | FY15 Q1 |
C. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY15 Q2 |
Completed | FY15 Q1 |
D. FDA researchers to submit mid-year progress reports for intramural studies |
FY16 Q2 |
Completed | TBD |
E. FDA researchers to submit final reports and complete poster/oral presentations |
FY17 Q1 |
Completed | TBD |
Key Projects Legend
Milestone Status | Definition |
---|---|
Not Yet Started | Work for specific milestone has not yet been started. |
Completed | Milestone and/or overall project is completed. |
On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |